Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy?

We recently published 10 Most Popular Analyst Calls to Watch This Week. VanEck Pharmaceutical ETF (NASDAQ:PPH) is one of the trending stocks.

Many analysts are picking healthcare stocks as indicators point to a potential rebound in the sector. Karen Finerman, CEO & Co-founder, Metropolitan Capital Advisors, said in a recent program on CNBC that she likes the VanEck Pharmaceutical ETF. Here is what the analyst said:

“VanEck Pharmaceutical ETF (NASDAQ:PPH), this is ETF, big cap pharma. I like it. I think there’s value in this space.”

While we acknowledge the potential of PPH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.